Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
49 hedge funds and large institutions have $5.83M invested in Monogram Orthopaedics in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
17% more funds holding
Funds holding: 42 → 49 (+7)
8% more capital invested
Capital invested by funds: $5.42M → $5.83M (+$411K)
0.43% more ownership
Funds ownership: 5.22% → 5.65% (+0.43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$291K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$67.7K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$53K |
| 4 |
Goldman Sachs
New York
|
+$45.3K |
| 5 |
BlackRock
New York
|
+$34.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$44.8K |
| 2 |
Morgan Stanley
New York
|
-$28.8K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$21.8K |
| 4 |
Jane Street
New York
|
-$18.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$1.56K |
MGRM Hedge Fund Activity: Q2 2025 in Review
49 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q2 2025, worth a combined $5.83M — up 7.6% from $5.42M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MGRM positions and 3 closed out — a net gain of 8 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $291K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $44.8K sold.
- 49 institutional investors held Monogram Orthopaedics (MGRM) as of Q2 2025, up from 42 in Q1 2025.
- Funds reported $5.83M of Monogram Orthopaedics stock for Q2 2025, up 7.6% quarter-over-quarter.
- 11 funds opened new Monogram Orthopaedics positions in Q2 2025 and 3 closed out, a net change of +8 holders.
- The largest Monogram Orthopaedics buyer in Q2 2025 was Vanguard Group, an estimated $291K added.
- The largest Monogram Orthopaedics seller in Q2 2025 was Two Sigma Investments, an estimated $44.8K sold.
Based on aggregated 13F filings for Q2 2025.